NVNO — enVVeno Medical Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1661053 ·
Last close
$11.25
Market Cap
$7.51M
52W High
$13.44
52W Low
$9.01
ADV30
12,024
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -4,062,000 | -3,849,000 | 26,097,000 | 2,597,000 | 2,350,000 |
| Dec 2025 | 0 | — | -4,013,000 | -3,736,000 | 29,562,000 | 3,065,000 | 2,432,000 |
| Sep 2025 | 0 | — | -4,883,000 | -4,539,000 | 32,352,000 | 1,544,000 | 2,905,000 |
| Jun 2025 | 0 | — | -7,049,000 | -6,694,000 | 36,577,000 | 2,044,000 | 3,520,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,568,000
Investing CF
$15,856,000
Financing CF
$1,023,000
CapEx
$-13,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-39.55
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-171,327,000
Inventory
—
Receivables
—
ST Investments
$25,147,000
EBIT TTM
$-20,899,000
Pretax Income TTM
$-19,472,000
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -20,899,000 | -19,472,000 | 29,562,000 | 2,432,000 | — | -15,568,000 |
| Dec 2024 | 0 | -23,826,000 | -21,819,000 | 44,954,000 | 2,795,000 | — | -16,838,000 |
| Dec 2023 | 0 | -25,238,000 | -23,516,000 | 48,635,000 | 2,435,000 | — | -18,858,000 |
| Dec 2022 | 0 | -24,932,000 | -24,669,000 | 41,661,000 | 2,932,000 | — | -15,619,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.19
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| USAQ | QHSLab, Inc. | $7.82M | $0.52 | — |
| TNON | Tenon Medical, Inc. | $8.01M | $0.69 | — |
| NDRA | ENDRA Life Sciences Inc. | $6.60M | $5.20 | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $6.34M | $2.65 | — |
| MHUAF | Meihua International Medical Technologies Co., Ltd. | $6.33M | $7.40 | — |
News headlines (Yahoo Finance, 1h cache)
enVVeno Medical Discusses FDA IDE Approval in Virtual Investor "What This Means" Segment
2026-05-12 13:02 · Yahoo
enVVeno Medical Reports First Quarter 2026 Financial Results and Provides Business Update Highlighting Strategic Advancement of the enVVe System
2026-05-07 12:05 · Yahoo
One enVVeno Medical Insider Raised Their Stake In The Previous Year
2026-05-06 18:58 · Yahoo
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
2026-04-29 12:05 · Yahoo
enVVeno Medical Reports Full Year 2025 Financial Results and Highlights Strategic Advancement of enVVe(R) System
2026-03-27 12:30 · Yahoo
NorthStrive Fund II LP Calls on enVVeno Medical to Halt Clinical Spending Plans and Call Special Shareholder Meeting to Vote on Strategic Alternatives
2026-03-03 19:40 · Yahoo
enVVeno Medical Regains Compliance with Nasdaq Minimum Bid Price Requirement
2026-02-04 13:30 · Yahoo
enVVeno Medical Announces Reverse Stock Split
2026-01-15 13:00 · Yahoo
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
2025-11-26 13:48 · Yahoo
Insider Buyers Lose Additional US$294k As enVVeno Medical Dips To US$6.5m
2025-11-22 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.